World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
121
Citations
97947
World Ranking
3524
National Ranking
352

Stephen MacMahon publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Stephen MacMahon sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 420 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Stephen MacMahon D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Stephen MacMahon sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 121 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2015 - Fellow of the Australian Academy of Health and Medical Science
  • 2012 - Fellow of the Australian Academy of Science
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Stephen MacMahon is affiliated with the University of Oxford in the United Kingdom and has contributed extensively to medical research, particularly in the fields of medicine and cardiovascular health. The primary area of their research lies within cardiology and cardiovascular medicine, supported by a significant body of work spanning related subfields such as endocrinology, diabetes and metabolism, economics and econometrics, genetics, and surgery.

Their research topics prominently focus on blood pressure and hypertension studies, heart rate variability and autonomic control, hormonal regulation and hypertension, lipoproteins and cardiovascular health, health systems including economic evaluations and quality of life, diabetes with associated cardiovascular risks, as well as dementia and cognitive impairment research.

Stephen MacMahon's recent published works include:

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure (2021, The Lancet)
  • Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death (2021, The Lancet)
  • Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials (2022, The Lancet)
  • Obesity as a risk factor for COVID-19 mortality in women and men in the UK biobank: Comparisons with influenza/pneumonia and coronary heart disease (2020, Diabetes Obesity and Metabolism)
  • Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis (2021, The Lancet Oncology)

The scientist frequently publishes in leading journals, with notable venues including:

  • The Lancet
  • Diabetes Obesity and Metabolism
  • The Lancet Diabetes & Endocrinology
  • Lung Cancer
  • UNC Libraries

Stephen has collaborated regularly with other researchers in the field, with frequent co-authors including:

  • Mark Woodward
  • John Chalmers
  • Colin Baigent
  • Anthony Rodgers
  • Neil R Poulter

Recognition of their scientific contributions is reflected in fellowships granted by several professional academies, including the Australian Academy of Health and Medical Science in 2015, the Australian Academy of Science in 2012, and The Academy of Medical Sciences in the United Kingdom.

Best Publications

  • Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

    Anushka Patel;Stephen MacMahon;John Chalmers

  • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

    A. Tonkin;P. Alyward;D. Colquhoun;P. Glasziou

  • Blood pressure, stroke, and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

    S Macmahon;R Peto;J E Cutler;R Collins

  • Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context

    R Collins;R Peto;S MacMahon;P Hebert

  • Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

    S. MacMahon;B. Neal;C. Tzourio;A. Rodgers

  • Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials.

    Anthony Rodgers;Natalie Walker;S Schug;A McKee

  • Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

    B Neal;S MacMahon;N Chapman

  • ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.

    R Collins;R Peto;M Flather;S Parish

  • Interpretation of the evidence for the efficacy and safety of statin therapy.

    Rory Collins;Christina Reith;Jonathan Emberson;Jane Armitage

  • Severe Hypoglycemia and Risks of Vascular Events and Death

    Sophia Zoungas;Sophia Zoungas;Anushka Patel;John Chalmers;Bastiaan E. de Galan;Bastiaan E. de Galan

  • ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION

    D Hunt;J Varigos;F Dienstl;P Lechleitner

  • Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality.: A collaborative meta-analysis of high-risk population cohorts

    Marije van der Velde;Kunihiro Matsushita;Josef Coresh;Brad C. Astor

  • Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.

    Christophe Tzourio;Craig Anderson;Neil Chapman;Mark Woodward

  • Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials

    F Turnbull;Bruce Neal;Charles Algert;John Chalmers

  • ISIS-4 - A randomised factorial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patient with suspected acute myocardial-infarction.

    R Collins;R Peto;M Flather;S Parish

  • Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes

    Toshiharu Ninomiya;Vlado Perkovic;Bastiaan E de Galan;Bastiaan E de Galan;Sophia Zoungas

  • Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease

    R Collins;S MacMahon

  • Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials.

    Fiona Turnbull;B Neal;T. Ninomiya

  • Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial

    J O'Brien;H Duncan;G Kirsh;V Allen

  • Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis

    Xinfang Xie;Emily Atkins;Jicheng Lv;Jicheng Lv;Alexander Bennett

Frequent Co-Authors

Mark Woodward
Mark Woodward Imperial College London
John Chalmers
John Chalmers University of New South Wales
Bruce Neal
Bruce Neal George Institute for Global Health
Anushka Patel
Anushka Patel University of New South Wales
Anthony Rodgers
Anthony Rodgers University of New South Wales
Vlado Perkovic
Vlado Perkovic George Institute for Global Health
Craig S. Anderson
Craig S. Anderson George Institute for Global Health
Rory Collins
Rory Collins University of Oxford
Toshiharu Ninomiya
Toshiharu Ninomiya Kyushu University
Bruce E. Kemp
Bruce E. Kemp Australian Catholic University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn't always mean following the traditional MD pathway. There are numerous online degrees and alternative career paths within healthcare that can be both rewarding and affordable.

Nursing remains one of the most popular fields, especially for those looking for flexibility. For working professionals or those on a budget, cheapest np school online options make it possible to advance your qualifications while minimizing costs. Similarly, many students start their journey with cheap online nursing programs, which focus on foundational skills needed for entry-level positions.

Those with an associate degree in nursing can further boost their credentials by enrolling in rn to bsn cheapest programs, designed to expand both clinical and leadership skills. If you're interested in research, education, or leadership, exploring phd nursing programs online opens doors to advanced roles and academic careers.

Exploring these affordable online pathways allows you to tailor your education to your goals, budget, and schedule—making a fulfilling healthcare career more accessible than ever.

Best Scientists Citing Stephen MacMahon

Trending Scientists

Recently Published Articles